The Effectiveness of Enoant in the Treatment of Bronchitis in Children

  • Igor Bogadelnikov
  • Renata E. Verem‘eva
  • Yuliya Vyaltseva
Conference paper
Part of the NATO Science for Peace and Security Series A: Chemistry and Biology book series (NAPSA)


We administered Enoant for the first time in 1993 as a part of a complex treatment for children with recurrent bronchitis (RB). These patients typically have significant disorder of their microbial ecological system, enhancement of lipid peroxidation, and decreased immune responsiveness. The reason for choosing Enoant was a high content of flavonoids, its impact on the microbial biocenosis of the intestine due to active acidity, and finally the absence of alcohol in the medication. To study the effect of Enoant on the microbial ecological system of the intestine and the immune system of children with RB, we observed 142 children aged from 4 to 7 years old. All patients were in the state of remission. The nutritional supplement Enoant was administered 7 ml three times per a day before meals, which equals 56 mg of coloring substance per intake. The course of treatment was 15 days. The control groups received the eubiotics Bifikol diet in combination with phytotherapy. Our research has shown the clinical effectiveness of Enoant, which was accompanied by improvement of bacteriological parameters of intestinal microflora and immune indicators in serum, i.e. the increased activity of complement, lysozyme, phagocytic rates of reaction, concentration of immunoglobulins A and M, the number of T-lymphocytes and reduced level of immunoglobulin E and the CEC.


Microbial Structure Intestinal Microflora Opportunistic Bacterium Significant Disorder Intestinal Dysbiosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Mechnikov II (1961) Studies of human nature. Publishing House of the USSR Academy of Sciences, MoscowGoogle Scholar
  2. 2.
    Berezhnoy VV, Unichn NK, Orlyuk IB et al (1999) Intestinal dysbiosis in children. Perinatol Pediatr 1:25–30Google Scholar
  3. 3.
    Tyazhka AV, Pochynok TV, Kazakova LM et al (2010) Functional food for children with intestinal dysbiiosis. Perinatol Pediatr 1(41):136–140Google Scholar
  4. 4.
    Zagorujko YA, Bogalelnikov IV, Bogdanov NN et al (2000) Bioactive properties of grapes and wine. Magarach Viticulture Winemaking 4:25–26Google Scholar
  5. 5.
    Melnychenko OG, Kirsanova MA, Krivorutchenko YL (2001) Investigation of the effect of Enoant on microorganisms. Crimea Dev 1:39–41Google Scholar
  6. 6.
    Belousov YV (2005) Probiotics and prebiotics in correction of dysbiosis in children. Pediatr Obstet Gynecol 5:57–60Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Igor Bogadelnikov
    • 1
  • Renata E. Verem‘eva
    • 1
  • Yuliya Vyaltseva
    • 1
  1. 1.S.I. Georgievsky Crimean State Medical UniversitySimferopol, CrimeaUkraine

Personalised recommendations